Additional information
| Water Retention | Minimal |
|---|---|
| Hepatotoxicity | No significant hepatotoxicity reported |
| Lab Test | Monitoring of IGF-1 levels may be used to assess efficacy |
| Strength | 2 mg |
| Also known as | TH9507 |
| Blood pressure | Typically no significant impact on blood pressure |
| Trade name | Egrifta |
| Storage conditions | Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F) |
| Chemical name | (trans-3-Hexenoyl)lysyl-threonyl-threonyl-threonyl-lysyl-threonyl-lysyl-threonyl-lysyl-threonyl-lysyl-threonyl-lysyl-threonyl |
| Formula | C221H366N72O67S |
| Substance class | Peptide hormone |
| Main action | Growth hormone-releasing hormone (GHRH) analog |
| Half-life | Approximately 38 minutes |
| Dosage (medical) | 2 mg injected subcutaneously once daily |
| Dosage (sports) | Not applicable as it is not typically used for sports enhancement |
| Effects | Increases natural production of growth hormone |
| Side effects | Injection site reactions (redness, itching, pain), muscle aches, swelling, and potential increase in blood sugar levels |
| Use in sports | Not commonly used due to its specific medical application for reducing excess abdominal fat in HIV-infected patients with lipodystrophy |
| Manufacturer | Pharmaceutical |
Equispec 400 Boldenon-Undecylenat-Spektrum-Anabole
Balkan Pharma Danabol 10 mg 60 Tabletten
Yasmin Schering
HUMULIN-R CARTRIDGE Eli Lilly
PCT INTEX PHARMA
Alpha Pharma Alphabol 10 mg 60 Tabletten
Boldenone undecylenate 200 mg Moldavian Pharma
Thaiger Pharma Veboldex 400 mg 10 ml (Equipoise)
Bvs Labs Boldenon 300mg 10ml
Watson Pharmaceuticals Boldelong 400 mg 10 ml (Boldenon)
NORDITROPIN Novo Nordisk 

Reviews
There are no reviews yet.